Oppenheimer Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.44M Buy
16,547
+1,311
+9% +$510K 0.07% 294
2025
Q1
$6.63M Buy
15,236
+7,380
+94% +$3.21M 0.08% 264
2024
Q4
$2.9M Buy
7,856
+158
+2% +$58.3K 0.04% 449
2024
Q3
$4M Buy
7,698
+118
+2% +$61.4K 0.05% 378
2024
Q2
$4.11M Buy
7,580
+2,386
+46% +$1.29M 0.05% 352
2024
Q1
$2.69M Sell
5,194
-3,995
-43% -$2.07M 0.04% 410
2023
Q4
$4.33M Buy
9,189
+279
+3% +$132K 0.06% 326
2023
Q3
$3.88M Buy
8,910
+862
+11% +$375K 0.06% 335
2023
Q2
$3.58M Buy
8,048
+4,327
+116% +$1.92M 0.05% 366
2023
Q1
$1.71M Sell
3,721
-932
-20% -$429K 0.03% 539
2022
Q4
$2.39M Sell
4,653
-2,698
-37% -$1.38M 0.04% 429
2022
Q3
$3.34M Sell
7,351
-23
-0.3% -$10.4K 0.06% 324
2022
Q2
$3.56M Buy
7,374
+1,646
+29% +$794K 0.06% 330
2022
Q1
$2.81M Buy
5,728
+960
+20% +$471K 0.04% 428
2021
Q4
$2.21M Sell
4,768
-2,090
-30% -$968K 0.03% 525
2021
Q3
$2.56M Buy
6,858
+1,697
+33% +$633K 0.04% 456
2021
Q2
$1.97M Buy
5,161
+1,384
+37% +$528K 0.03% 546
2021
Q1
$1.36M Buy
3,777
+316
+9% +$113K 0.02% 636
2020
Q4
$1.11M Buy
+3,461
New +$1.11M 0.02% 660
2020
Q2
Sell
-441
Closed -$99K 1170
2020
Q1
$99K Sell
441
-313
-42% -$70.3K ﹤0.01% 1108
2019
Q4
$229K Sell
754
-32
-4% -$9.72K ﹤0.01% 1029
2019
Q3
$189K Sell
786
-820
-51% -$197K ﹤0.01% 1048
2019
Q2
$455K Sell
1,606
-66
-4% -$18.7K 0.01% 841
2019
Q1
$480K Sell
1,672
-2,542
-60% -$730K 0.01% 817
2018
Q4
$1.11M Buy
4,214
+1,005
+31% +$264K 0.03% 530
2018
Q3
$878K Buy
3,209
+199
+7% +$54.4K 0.02% 651
2018
Q2
$716K Buy
3,010
+79
+3% +$18.8K 0.02% 687
2018
Q1
$643K Sell
2,931
-430
-13% -$94.3K 0.02% 715
2017
Q4
$638K Hold
3,361
0.02% 723
2017
Q3
$638K Buy
3,361
+331
+11% +$62.8K 0.02% 727
2017
Q2
$570K Buy
3,030
+754
+33% +$142K 0.02% 743
2017
Q1
$375K Buy
+2,276
New +$375K 0.01% 861